In 2006, a Rise in Ophthalmic Surgeries
This article was originally published in Start Up
Executive Summary
The diseases of the eye--cataracts, age-related macular degeneration and presbyopia--are largely degenerative conditions that are the result of aging and are every bit as prevalent as cardiovascular disease and the aches and pains that accompany joint degeneration. In 2006, ophthalmic surgical procedures represented approximately 23.2% of all surgeries performed in the US, according to "US Surgical Procedure Volumes," a report recently issued by the Medtech Insight division of Windhover Information, and procedure numbers are expected to climb at a compound annual growth rate of 4.2% through 2014.
You may also be interested in...
Deal Statistics Quarterly, Q1 2007
We present another installment of our quarterly review of dealmaking-for January-March 2007. Our data comes from Windhover's Strategic Transactions Database, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics and research industries.
Deal Statistics Quarterly, Q1 2007
We present another installment of our quarterly review of dealmaking-for January-March 2007. Our data comes from Windhover's Strategic Transactions Database, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics and research industries.
An Early Peek at Glaucoma Devices
The clinical community has long been searching for a safe and effective surgical alternative to drugs for glaucoma, but the field has moved slowly. A decade ago, non-invasive laser procedures began earning a place as a second-line therapy with limited durability. Invasive surgeries are reserved for end-stage glaucoma because of their complexity, their serious complications, and their high failure rates. Venture firms believe a large, unmet clinical need represents a new $1 billion device market, and the pace of glaucoma device company creation is picking up.